Glucose metabolism and insulin sensitivity are key factors in the pathogenesis of NAFLD, and insulin signaling is involved in regulating fatty acid metabolism through upregulation of genes involved in de novo lipogenesis and downregulation of lipid-degradation pathway genes [37]. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.